Sloan Sehr
Vice President, Sales – U.S.
Cluep
Optimizing Targeted Media
In his role at Cluep, Sloan Sehr is at the forefront of innovation and disrupting the status quo, helping lead the commercialization of their proprietary technology, which uses advanced AI models to optimize targeted engagement with non-personal media, bolstering the efficacy of omnichannel marketing programs.
The Cluep platform uniquely identifies targeted audiences by discerning people’s self-expressed signals across social including intent, needs, desires, interests, life events, and feelings that align with client goals and media targeting parameters. The technology derives credentialed insight and feelings from text-based posts, as well as through influencers/brands and industry groups being followed, images shared, and/or audio and video consumed, in order to yield qualified audiences. In real-time, Cluep subsequently engages the qualified segment with targeted messaging as they move outside social platforms throughout their mobile app/website journey, yielding impressive key performance indicators (KPIs).
Sloan has been a disrupter for nearly 20 years with prominent roles at Yahoo!, IZEA, Chango, and Rubicon Project. For the past eight years, he has been managing the U.S. division of Cluep with a focus on supporting the Pharmaceutical, Healthcare, and Life Science verticals. In that role, he is helping push the pharmaceutical marketing industry forward, guiding the utilization of Cluep’s transformational engagement technology and delivering results that are 3x to 5x above industry average, according to third-party measurement partners.
“Our team and our clients have been working with Sloan and Cluep for a few years and have come to depend on Sloan, his personal insights, and perspective for optimizing engagement through innovative and intelligent technology, across audiences and channels,” says Mike Marett, Founder & CEO, Confideo. “As a result, we are delivering highly efficient and efficacious results for our trusted clients.”
